TamPub
    • Suomeksi
    • In English
Tampereen yliopiston julkaisuarkistoTampere University Institutional Repository
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   TamPub etusivu
  • TamPub
  • Artikkelit
  • Näytä viite
  •   TamPub etusivu
  • TamPub
  • Artikkelit
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial

Veerus, Piret; Hovi, Sirpa-Liisa; Sévon, Tiina; Hunter, Myra; Hemminki, Elina (2012)

 
 
Tweet Tiedostoon pääsyä rajoitettu
 
Tiedostoon pääsyä rajoitettu
Avaa tiedosto
The_effect_of_hormone_2012.pdf (488.1Kt)
Lataukset: 



Veerus, Piret
Hovi, Sirpa-Liisa
Sévon, Tiina
Hunter, Myra
Hemminki, Elina
2012

BMC Research Notes 5
176
Terveystieteiden yksikkö
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
doi:10.1186/1756-0500-5-176
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
http://urn.fi/URN:NBN:fi:uta-201208071024

Kuvaus

BioMed Central open access
Tiivistelmä
Background

For postmenopausal women, the main reason to start hormone therapy (HT) is to reduce menopausal symptoms and to improve quality of life (QOL). The aim of this study was to analyse the impact of HT on different aspects of symptom experience and QOL during a randomised trial.

A total of 1823 postmenopausal women were recruited into the Estonian Postmenopausal Hormone Therapy (EPHT) trial in 1999–2001. Women were randomised to blind HT, open-label HT, placebo or non-treatment arm. After one year in the trial, a questionnaire was mailed and 1359 women (75%) responded, 686 in the HT arms and 673 in the non-HT arms. Mean age at filling in the questionnaire was 59.8 years. The questionnaire included Women's Health Questionnaire (WHQ) to assess menopause specific QOL of middle-aged women together with a 17-item questionnaire on symptoms related to menopause, a question about painful intercourse, and a question about women's self-rated health.
Results

After one year in the trial, fewer women in the HT arms reported hot flashes, trouble sleeping, and sweating on the symptom questionnaire. According to WHQ, women in the HT arms had fewer vasomotor symptoms, sleep problems, and problems with sexual behaviour, but more menstrual symptoms; HT had no effect on depression, somatic symptoms, memory, attractiveness, or anxiety. A smaller proportion of women reported painful intercourse in the HT arms. There were no significant differences between the trial arms in women’s self-rated subjective health.
Conclusions

The results from the EPHT trial confirm that HT is not justified for treating symptoms, other than vasomotor symptoms, among postmenopausal women. WHQ proved to be a useful and sensitive tool to assess QOL in this age group of women.
Kokoelmat
  • Artikkelit [3649]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[at]uta.fi | Yhteydenotto | Tietosuoja
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019-)Tiedekunta (2017 - 2018)Yksikkö (2011-2016)Tiedekunta (-2010)Oppiaineet ja tutkinto-ohjelmatAvainsanatJulkaisusarjatJulkaisuajatKokoelmat
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[at]uta.fi | Yhteydenotto | Tietosuoja